4//SEC Filing
Emergent BioSolutions Inc. 4
Accession 0001140361-17-022459
$EBSCIK 0001367644operating
Filed
May 25, 8:00 PM ET
Accepted
May 26, 1:22 PM ET
Size
15.2 KB
Accession
0001140361-17-022459
Insider Transaction Report
Form 4
JOULWAN GEORGE A
Director
Transactions
- Other
Common Stock
2016-08-01+152→ 20,937 total - Other
Common Stock
2016-08-01+604→ 21,541 total - Other
Employee Stock Option (Right to buy)
2016-08-01+346→ 3,946 totalExercise: $15.97Exp: 2020-07-17→ Common Stock (3,946 underlying) - Award
Common Stock
2017-05-25+8,259→ 30,377 total - Other
Common Stock
2016-08-01+577→ 22,118 total - Other
Employee Stock Option (Right to buy)
2016-08-01+905→ 10,305 totalExercise: $18.64Exp: 2021-05-22→ Common Stock (10,305 underlying)
Footnotes (8)
- [F1]In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in May 2017.
- [F2]In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in May 2017 and May 2018.
- [F3]In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in May 2017, May 2018 and May 2019.
- [F4]Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.
- [F5]These restricted stock units vest in three equal annual installments beginning on the earlier of (i) the anniversary of the date of grant or (ii) one business day prior to date of the Company's next annual meeting; provided that the individual is serving on the Board on such date.
- [F6]Consists of an option granted under the company's stock incentive plan as amended and restated. In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant.
- [F7]The option grant is fully vested.
- [F8]The option grant vests in May 2017.
Documents
Issuer
Emergent BioSolutions Inc.
CIK 0001367644
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001367644
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 1:22 PM ET
- Size
- 15.2 KB